Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/688566 stock hub

SHA/688566 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688566is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.6B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688566

In the news

Latest news · SHA/688566

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E22.2

P25 23.5P50 41.3P75 83.2

ROE10.5

P25 -0.9P50 4.1P75 8.8

ROIC12.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688566 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

CNY

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,326
Employees Change	-1%
Employees Change Percent	-0.08
Enterprise value	CNY 4.9B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100004041
Last refreshed	2026-05-10
Market cap	CNY 5.6B
Price	CNY 28.2
Price currency	CNY
Rev Per Employee	746,556.85x
Sector	Healthcare
Sic	2834
Symbol	sha/688566
Website	https://www.jbepharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.52%
EV Earnings	19.18x
EV/EBIT	20.29x
EV/EBITDA	18.76x
EV/FCF	68.65x
EV/Sales	4.92x
FCF yield	1.26%
P/B ratio	2.25x
P/E ratio	22.22x
P/S ratio	5.68x
PE Ratio3 Y	23.69x
PE Ratio5 Y	27.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.25%
EBITDA Margin	26.23%
FCF margin	7.17%
Gross margin	89.59%
Gross Profit	CNY 887.6M
Gross Profit Growth	9.82%
Gross Profit Growth Q	12.92%
Gross Profit Growth3 Y	13.86%
Gross Profit Growth5 Y	11.95%
Net Income	CNY 254.1M
Net Income Growth	17.44%
Net Income Growth Q	-15.22%
Net Income Growth Years	4%
Net Income Growth3 Y	15.69%
Net Income Growth5 Y	14.06%
Pretax Margin	29.7%
Profit Margin	25.65%
Profit Per Employee	CNY 191,462
Profitable Years	10
ROA	5.7
Roa5y	5.84
ROCE	9.28
ROE	10.51
Roe5y	10.06
ROIC	12.2
Roic5y	21.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.9%
Cagr3y	-2.8%
Cagr5y	6.22%
Div CAGR3	17.57%
EPS Growth	15.43
EPS Growth Q	-16
EPS Growth Years	1
EPS Growth3 Y	12.94
EPS Growth5 Y	11.89
FCF Growth	306.03%
FCF Growth5 Y	-5.36%
OCF Growth	2.79%
OCF Growth3 Y	-8.27%
OCF Growth5 Y	9.92%
Revenue Growth	9.58x
Revenue Growth Q	12.2x
Revenue Growth Quarters	7x
Revenue Growth Years	4x
Revenue Growth3 Y	13.29x
Revenue Growth5 Y	11.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.38
Assets	CNY 2.7B
Cash	CNY 770.2M
Current Assets	CNY 1.3B
Current Liabilities	CNY 134.3M
Debt	CNY 1.7M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.02
Equity	CNY 2.5B
Liabilities	CNY 222.7M
Long Term Assets	CNY 1.5B
Long Term Liabilities	CNY 88.4M
Net Cash	CNY 768.6M
Net Cash By Market Cap	CNY 13.67
Net Cash Growth	-14.87%
Net Debt EBITDA	CNY -2.96
Net Debt Equity	CNY -0.31
Net Debt FCF	CNY -10.83
Tangible Book Value	CNY 2.4B
Tangible Book Value Per Share	CNY 11.94
WACC	6.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.35
Inventory Turnover	2.87
Net Working Capital	CNY 353.5M
Quick ratio	8.73
Working Capital	CNY 1.1B
Working Capital Turnover	CNY 0.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.74%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.78
Dividend Years	6
Dividend Yield	2.77%
Last Dividend	CNY 0.26
Payout Ratio	40.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.88%
200-day SMA	31.65
3Y total return	-8.18%
50-day SMA	29.87
50-day SMA vs 200-day SMA	50under200
5Y total return	35.21%
All Time High	54.97
All Time High Change	-48.7%
All Time High Date	2020-05-19
All Time Low	14.98
All Time Low Change	88.25%
All Time Low Date	2022-04-27
ATR	0.87
Beta	0.4
Beta1y	0.05
Beta2y	0.34
Ch YTD	-5.53
High	28.26
High52	44.68
High52 Date	2025-09-03
High52ch	-36.88%
Low	27.92
Low52	23.66
Low52 Date	2025-05-08
Low52ch	19.19%
Ma50ch	-5.6%
Price vs 200-day SMA	-10.89%
RSI	37.27
RSI Monthly	49.65
RSI Weekly	42.91
Sharpe ratio	0.71x
Sortino ratio	1.35
Total Return	1.03%
Tr YTD	-5.53
Tr1m	-10.76%
Tr1w	0.18%
Tr3m	-1.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 240.3M
Operating Income Growth	-17.32
Operating Income Growth Q	-16.27
Operating Income Growth3 Y	14.34
Operating Income Growth5 Y	13.06
Operating margin	24.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	61,134,331%
Net Borrowing	-2,200,000
Shares Insiders	32.65%
Shares Institutions	5.19%
Shares Out	199,430,865
Shares Qo Q	-1.06%
Shares Yo Y	1.74%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 71M
Average Volume	2,986,191.8x
Bv Per Share	12.41
CAPEX	CNY -111.3M
Ch1m	-10.76
Ch1w	0.18
Ch1y	17.99
Ch3m	-1.26
Ch3y	-12.18
Ch5y	23.41
Ch6m	-10.9
Change	0.43%
Change From Open	0.36
Close	28.08
Days Gap	0.07
Depreciation Amortization	19,561,806
Dollar Volume	38,157,307.2
Earnings Date	2026-04-28
EBIT	CNY 240.3M
EBITDA	CNY 259.8M
EPS	CNY 1.27
F Score	5
FCF	CNY 71M
FCF EV Yield	1.46x
FCF Per Share	CNY 0.36
Financing CF	-53,318,617
Fiscal Year End	December
Founded	2,001
Goodwill	35,325,610
Graham Number	18.82533
Graham Upside	-33.24
Income Tax	CNY 41.7M
Investing CF	-68,922,281
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	CNY 17.85
Lynch Upside	-36.7
Ma150	30.51
Ma150ch	-7.57%
Ma20	30.19
Ma20ch	-6.58%
Net CF	60,098,083
Next Earnings Date	2026-08-28
Open	28.1
P FCF Ratio	79.22
P OCF Ratio	30.84
Payment Date	2025-09-17
Position In Range	82.35
Ppne	1,039,669,931
Price Date	2026-05-08
Price EBITDA	CNY 21.65
Ptbv Ratio	2.35
Relative Volume	0.45x
Revenue	990,680,945x
Tax By Revenue	4.21x
Tax Rate	14.18%
Tr6m	-10.9%
Volume	1,353,096

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688566 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$0.78 annual per share

Payout ratio

+40.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+1.0%

Dividend yield + buyback yield combined

Performance

SHA/688566 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688566?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.2%

Share of float held by funds and institutions

Insider ownership

+32.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.7%

Negative means the company is buying back shares.

Technical

SHA/688566 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.3

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688566

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688566 stock rating?

sha/688566 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688566 analysis?

The full report lives at /stocks/sha/688566/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688566?

The latest report frames sha/688566 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688566 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.